Akeso Investor Relations Material
Latest events
H2 2024
Akeso
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Akeso Inc
Access all reports
Akeso Inc is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of innovative therapies. The company focuses on oncology, immunology, and other therapeutic areas, utilizing its proprietary research platforms to develop monoclonal antibody drugs. The company is headquartered in Zhongshan, China, and its shares are listed on the SEHK.
Key slides for Akeso Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
9926
Country
🇭🇰 Hong Kong